Aytu Biopharma (AYTU) Net Income Growth (5y) (2019 - 2025)
Aytu Biopharma (AYTU) Net Income Growth (5y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.86 Bn | 88.00 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.98 Bn | 32.24 Bn | 1.97 Bn |
| 3 | Zoetis | 32.48 Bn | 30.54 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.01 Bn | 20.86 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.02 Bn | 22.02 Bn | - |
| 7 | Viatris | 20.40 Bn | 18.59 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.46 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.74 Bn | 12.31 Bn | 785.00 Mn |
| 10 | Aytu Biopharma | 21.55 Mn | -5.17 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 14.97% |
| Mar 31, 2025 | 14.99% |
| Dec 31, 2024 | 15.13% |
| Sep 30, 2024 | 15.74% |
| Jun 30, 2024 | 23.01% |
| Mar 31, 2024 | 33.17% |
| Dec 31, 2023 | 29.09% |
| Sep 30, 2023 | 28.63% |
| Jun 30, 2023 | 11.70% |
| Mar 31, 2023 | 0.88% |
| Dec 31, 2022 | -9.82% |
| Sep 30, 2022 | 31.19% |
| Jun 30, 2022 | 24.83% |
| Mar 31, 2022 | -60.91% |
| Dec 31, 2021 | -20.28% |
| Sep 30, 2021 | -34.27% |
| Jun 30, 2021 | -4.14% |
| Dec 31, 2020 | -23.37% |
| Sep 30, 2020 | -13.60% |
| Jun 30, 2020 | -27.57% |